UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046511
Receipt number R000052268
Scientific Title Late Vascular Response Following Endovascular Treatment with Drug-coating Balloon for Femoropopliteal Artery Lesions as Assessed by Intravascular Ultrasound
Date of disclosure of the study information 2022/01/01
Last modified on 2021/12/28 19:02:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Late Vascular Response Following Endovascular Treatment with Drug-coating Balloon for Femoropopliteal Artery Lesions as Assessed by Intravascular Ultrasound

Acronym

ENLARGE study

Scientific Title

Late Vascular Response Following Endovascular Treatment with Drug-coating Balloon for Femoropopliteal Artery Lesions as Assessed by Intravascular Ultrasound

Scientific Title:Acronym

ENLARGE study

Region

Japan


Condition

Condition

Peripheral Artery Disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1. To evaluate the long-term vascular response after EVT for femoropopliteal artery lesions with DCB.
2. To assess the predictors of late lumen enlargement and restenosis after EVT for femoropopliteal artery lesions with DCB.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

change in IVUS-derived lumen volume index (1-year follow up - post EVT)

Key secondary outcomes

Change in vessel volume index (1-year follow-up - post-EVT)
Change in plaque volume index (1-year follow-up - post-EVT)
Change in mean lumen area (1-year follow-up - post-EVT)
Change in mean vessel area (1-year follow-up - post-EVT)
Change in mean plaque area (1-year follow-up - post-EVT)
Change in lumen volume index (post-EVT - baseline)
Change in vessel volume index (post-EVT - baseline)
Change in plaque volume index (post-EVT - baseline)
Change in mean lumen area (post-EVT - baseline)
Change in vessel area (post-EVT - baseline)
Change in mean plaque area (post-EVT - baseline)
Mean dissection angle at post-EVT
Maximum dissection angle at post-EVT
Mean dissection angle at 1-year
Maximum dissection angle at 1-year
Incidence of late lumen enlargement
Restenosis at 1 year as assessed by duplex ultrasound (PSVR: peak systolic velocity rate > 2.4m/s)
Late lumen loss (MLD at follow-up - MLD at post-EVT) by QVA
Acute gain (MLD at post-EVT - MLD at baseline) by QVA
Predictors for LLE at 1 year
Predictors for restenosis at 1 year
All-cause death, cardiac death, myocardial infarction, stroke, revascularization, amputation

Sub-group analysis:
Lesion length>20mm
Plaque burden>70%
Calcification angle>180
TASC classification
Hemodialysis
Diabetes mellitus
Sex
Small vessel
%diameter stenosis at post-DCB
Plaque type (lipid vs. fibrous vs. calcification)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients with symptomatic PAD undergoing EVT for superficial femoral artery or proximal popliteal artery with DCB.
2. Age 20 years or older.

Key exclusion criteria

1. Restenosis lesion.
2. Lesion treated with any stents.
3. Critical limb ischemia.
4. Life expectancy less than 1 year.
5. Pregnant or breastfeeding.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yasushi
Middle name
Last name Ueki

Organization

Shinshu University Hospital

Division name

Department of Cardiovascular Medicine

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto, Nagano

TEL

0263-37-3486

Email

yasushi522@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Keisuke
Middle name
Last name Machida

Organization

Shinshu University Hospital

Division name

Department of Cardiovascular Medicine

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto, Nagano

TEL

0263-37-3486

Homepage URL


Email

matchy0925@icloud.com


Sponsor or person

Institute

Department of Cardiovascular Medicine, Shinshu University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee, Shinshu University Faculty of Medicine

Address

3-1-1, Asahi, Matsumoto, Nagano

Tel

0263-37-2572

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

信州大学医学部附属病院(長野県)、長野市民病院(長野県)、長野赤十字病院(長野県)


Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 09 Month 01 Day

Date of IRB

2021 Year 11 Month 11 Day

Anticipated trial start date

2021 Year 12 Month 09 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observational study


Management information

Registered date

2021 Year 12 Month 28 Day

Last modified on

2021 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052268